Novonix Limited filed a Form 6-K reporting changes in director interests, with five directors each acquiring 195,938 share rights following shareholder approval.
Key takeaways
Five directors each received 195,938 share rights valued at $50,944 based on closing price on May 4, 2026.
Share rights were issued following shareholder approval at the AGM on April 15, 2026.
Directors affected: Robert Natter, Ron Edmonds, Jean Oelwang, Anthony Bellas, and Sharan Burrow.
No securities were traded during a closed period; prior written clearance was not required.
The transactions are administrative changes in director holdings, not market trades.